Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
06/2005
06/16/2005US20050129659 Synergistically effective combinations of dihaloacetamide compounds and interferon or ribavirin against HCV infections
06/16/2005US20050129658 For treating an inflammatory disorder such as mucositis, eye disorders, skin disorders, necrotizing enterocolitis
06/16/2005US20050129657 Interferon-alpha induced gene
06/16/2005US20050129625 Aerosolizing dry powder of interleukin-4 receptor with carbohydrage, lipid, buffer, peptide, protein, Group II metal, or oligopeptide excipient; small aerodynamic particle size; dispersion into gas stream to make inhalant
06/16/2005US20050129617 Contacting a T lymphocyte from the patient with a diagnostic epitope of an amino acid string including hydrophilic amino acids and one of Leucine, Methionine, Isoleucine, Phenylalanine, Alanine, Glycine, Valine, or Tryptophan
06/16/2005DE10352900A1 Method of making pharmaceutical composition for treatment of illnesses associated with deficient costimulation ability of T-cells, employs superagonistic monoclonal antibody
06/16/2005DE10351661A1 Künstliches Knorpelgewebe Artificial cartilage
06/16/2005DE10349115A1 Kombinationspräparat zur Behandlung der Sepsis Combination treatment of sepsis
06/16/2005DE10348550A1 Stabile wässrige G-CSF-haltige Zusammensetzungen A stable aqueous G-CSF-containing compositions
06/16/2005CA2565173A1 Interleukin-11 fusion proteins
06/16/2005CA2548454A1 Medicament comprising recombinant antibody against chemokine receptor ccr4
06/16/2005CA2548208A1 Angiogenesis affecting polypeptides, proteins, and compositions, and methods of use thereof
06/16/2005CA2548135A1 Synthetic hla binding peptide analogues and uses thereof
06/16/2005CA2548016A1 Use of limk-1, its analogues and ligands for the production of a medicament against a thrombus formation or blood clotting disease
06/16/2005CA2547955A1 Methods of preparing compounds useful as protease inhibitors
06/16/2005CA2547670A1 Treating infectious diseases using ice inhibitors
06/16/2005CA2547668A1 A biomimetic composition reinforced by a polyelectrolytic complex of hyaluronic acid and chitosan
06/16/2005CA2547618A1 Botulinum toxin treatment
06/16/2005CA2547355A1 Animal models of pancreatic adenocarcinoma and uses therefor
06/16/2005CA2547077A1 Dna damage repair inhibitors for treatment of cancer
06/16/2005CA2546796A1 Peptide hormones zalpha48 and zsig97
06/16/2005CA2546789A1 Gag binding proteins
06/16/2005CA2546710A1 Local intraosseous administration of bone forming agents and anti-resorptive agents, and devices therefor
06/16/2005CA2546649A1 Treatment of rheumatoid arthritis with hypoxia-inducible factor 1.alpha. antagonists
06/16/2005CA2546452A1 Recombinant adenylate cyclase toxin of bordetella induces t cell responses against tumoral antigens
06/16/2005CA2546448A1 Biomarkers for the efficacy of somatostatin analogue treatment
06/16/2005CA2546111A1 Biomarkers for the efficacy of calcitonin and parathyroid hormone treatment
06/16/2005CA2545543A1 Novel use of peptide compounds for treating central neuropathic pain
06/16/2005CA2545408A1 Selective neuropeptide y2 receptor agonists
06/16/2005CA2544890A1 Drug delivery vehicles and uses thereof
06/16/2005CA2539575A1 Method of removing transition metals, especially from metathesis reaction products
06/15/2005EP1541689A2 Hybrid proteins which form heterodimers
06/15/2005EP1541682A2 Generation and selection of recombinant varied binding proteins
06/15/2005EP1541677A1 Novel proteins and use thereof
06/15/2005EP1541675A2 Hybrid cells obtainable from antigen presenting cells
06/15/2005EP1541634A1 Process for the preparation of micronised collagen, and its therapeutic applications
06/15/2005EP1541589A1 Fused protein with the function of both hemolysis and anticoagulation and the use of it
06/15/2005EP1541585A1 Cxcr4 antagonist and use thereof
06/15/2005EP1541584A1 A group of novel synthetic antibiotic peptides
06/15/2005EP1541583A1 Non-t cell binding peptides and their uses
06/15/2005EP1541175A2 Combinations of sterol absorption inhibitor(s) with cardiovascular agent(s) for the treatment of vascular conditions
06/15/2005EP1541173A1 Method of degrading transcriptional factors of saccharometabolism-associated gene, method of inhibiting the degradation and degradation inhibitor
06/15/2005EP1541171A1 Therapeutics for diabetes mellitus
06/15/2005EP1541169A1 Use of limk-1, its analogues and ligands for the production of a medicament against a thrombus formation of blood clotting disease
06/15/2005EP1541168A1 Method of regulating animal reproduction
06/15/2005EP1541167A1 Antiallergic agent
06/15/2005EP1541166A1 Preventing cell death using segments of neural thread proteins
06/15/2005EP1541160A1 Body fat percentage-lowering agent or body fat percentage increase inhibitor
06/15/2005EP1541135A1 Hollow nanoparticle having modified cysteine residue and drug with the use thereof
06/15/2005EP1541132A1 Vaccine composition, method of preparing the composition and method of vaccinating vertebrates
06/15/2005EP1541036A1 Algae feeds for aquaculture and agriculture
06/15/2005EP1540559A2 Bioinformatic method for identifying surface-anchored proteins from gram-positive bacteria and proteins obtained thereby
06/15/2005EP1540004A2 Double stranded rna structures and constructs, and methods for generating and using the same
06/15/2005EP1539985A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
06/15/2005EP1539982A2 Glutathione production
06/15/2005EP1539974A1 Orthopoxvirus vectors, genes and products thereof
06/15/2005EP1539973A1 Modified adenoviral vectors for use in vaccines and gene therapy
06/15/2005EP1539971A1 Her-2/neu dna vaccine having anti-cancer activity
06/15/2005EP1539964A2 Collectin-complement activating protein chimeras
06/15/2005EP1539960A2 Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules
06/15/2005EP1539959A2 Ghrh analogues
06/15/2005EP1539958A2 Use of saccharomyces cerevisiae erg4 mutants for the expression of glucose transporters from mammals
06/15/2005EP1539956A2 GEF-H1b: BIOMARKERS, COMPLEXES, ASSAYS AND THERAPEUTIC USES THEREOF
06/15/2005EP1539955A2 G-protein coupled receptor polynucleotides and methods of use thereof
06/15/2005EP1539942A2 Nucleic acid molecules encoding a transmembrane serine protease 10, the encoded polypeptides and methods based thereon
06/15/2005EP1539941A2 Adzymes and uses thereof
06/15/2005EP1539933A2 Methods of organ regeneration
06/15/2005EP1539931A1 Differentiation modulating agents and uses therefor
06/15/2005EP1539816A1 Thrombin-cleavable factor x analogues
06/15/2005EP1539814A2 Full-length interferon gamma polypeptide variants
06/15/2005EP1539813A2 Polypeptides and nucleic acids encoding these and their use for the prevention, diagnosis or treatment of liver disorders and epithelial cancer
06/15/2005EP1539812A2 Osteoinductive biomaterials
06/15/2005EP1539811A2 Production of bispecific molecules using polyethylene glycol linkers
06/15/2005EP1539809A2 Hcv fusion proteins with modified ns3 domains
06/15/2005EP1539807A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
06/15/2005EP1539805A2 Nucleic acids and corresponsing proteins entitled 101p3a11 or phor-1 useful in treatment and detection of cancer
06/15/2005EP1539804A2 Synthesis and characterization of novel systems for guidance and vectorization of molecules of therapeutic interest towards target cells
06/15/2005EP1539803A2 Fluoro-alkyl-cyclopeptide derivatives having anti-integrin activity
06/15/2005EP1539802A2 Novel kcnq polypeptides, modulators thereof, and their uses in the treatment of mental disorders
06/15/2005EP1539801A2 Synthetic heparin-binding growth factor analogs
06/15/2005EP1539799A2 Crosslinked compounds and methods of making and using thereof
06/15/2005EP1539797A1 Process for manufacturing crystals of growth hormone
06/15/2005EP1539792A2 Cngh0005 polypeptides, antibodies, compositions, methods and uses
06/15/2005EP1539682A2 Process for the synthesis of intermediates useful for the synthesis of tubulin inhibitors
06/15/2005EP1539261A1 Metal implant coated under reduced oxygen concentration with osteoinductive protein
06/15/2005EP1539247A2 Alpha 5 beta 1 and its ability to regulate the cell survival pathway
06/15/2005EP1539246A2 Central airway administration for systemic delivery of therapeutics
06/15/2005EP1539245A2 Methods and materials for treating human papillomavirus infections
06/15/2005EP1539244A1 Use of dimethyl sulfone as isotonicity agent
06/15/2005EP1539241A2 Method of controlling pharmacokinetics of immunomodulatory compounds
06/15/2005EP1539236A2 Compositions, methods and kits relating to anti-platelet autoantibodies and inhibitors thereof
06/15/2005EP1539228A2 Novel composition and methods for the treatment of immune related diseases
06/15/2005EP1539227A2 Papaine containing pharmaceutical formulation resp. its use
06/15/2005EP1539225A2 Apparatus and methods for enzymatic escharotomy in burn induced compartment syndrome
06/15/2005EP1539224A1 Antimicrobial composition and method for use
06/15/2005EP1539222A1 Treatment for eye disorder
06/15/2005EP1539221A2 Transferrin fusion protein libraries
06/15/2005EP1539220A2 Compositions and method for enhanced mucosal delivery of interferon beta
06/15/2005EP1539219A2 Affinity small molecules for the epo receptor
06/15/2005EP1539216A2 Labelled somatostatin analogs backbone cyclized through metal complexation
1 ... 1427 1428 1429 1430 1431 1432 1433 1434 1435 1436 1437 1438 1439 1440 1441 1442 1443 1444 1445 1446 1447 ... 3163